Prashant Bavi
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 6
-
- Lymphoma Diagnosis and Treatment 13
- Genetic factors in colorectal cancer 9
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 9
- Cancer-related Molecular Pathways 7
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 8
- PI3K/AKT/mTOR signaling in cancer 7
- Peroxisome Proliferator-Activated Receptors 5
- Co-authors
- Shahab UddinKhawla S. Al‐KurayaFouad Al‐DayelMaqbool AhmedJehad AbubakerRong BuAbdul K. SirajZeenath Jehan
- Journals
- Cancer Research (7 papers)The Journal of Pathology (6 papers)The American Journal of Human Genetics (4 papers)
- Partner nations
- Saudi ArabiaUnited StatesCanada
In The Last Decade
Prashant Bavi
75 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 699
- Pathology and Forensic Medicine 679
- Oncology 929
- Molecular Biology 1.4k
- Endocrine and Autonomic Systems 140
Countries citing papers authored by Prashant Bavi
This map shows the geographic impact of Prashant Bavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Bavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Bavi more than expected).
Fields of papers citing papers by Prashant Bavi
This network shows the impact of papers produced by Prashant Bavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Bavi. The network helps show where Prashant Bavi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Prashant Bavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 8 | |
| 2 | 2014 | 39 | |
| 3 | 2013 | 25 | |
| 4 | 2012 | 13 | |
| 5 | 2011 | 131 | |
| 6 | 2011 | 8 | |
| 7 | 2010 | 40 | |
| 8 | 2010 | 30 | |
| 9 | 2010 | 21 | |
| 10 | 2010 | 51 | |
| 11 | 2009 | 34 | |
| 12 | 2009 | 53 | |
| 13 | 2008 | 66 | |
| 14 | Bortezomib(Velcade) induces p27kip1 associated cell cycle arrest and apoptosis through down-regulation of SKP2 ubiquitin ligase pathway in colorectal carcinoma | 2008 | 1 |
| 15 | 2008 | 94 | |
| 16 | 2008 | 18 | |
| 17 | 2008 | 21 | |
| 18 | Clinicopathological analysis of colorectal cancers withPIK3CA mutations in Middle Eastern population | 2007 | 1 |
| 19 | 2007 | 15 | |
| 20 | Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis. | 2006 | 13 |
About Prashant Bavi
Prashant Bavi is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 76 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Colorectal Cancer Treatments and Studies (9 papers), Genetic factors in colorectal cancer (9 papers), Ubiquitin and proteasome pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer-related Molecular Pathways (7 papers), Cancer, Lipids, and Metabolism (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). The work is most often cited by research in Cancer Research (699 citations), Pathology and Forensic Medicine (679 citations) and Oncology (929 citations). Prashant Bavi has collaborated with scholars based in Saudi Arabia, United States and Canada. Frequent co-authors include Shahab Uddin, Khawla S. Al‐Kuraya, Fouad Al‐Dayel, Maqbool Ahmed, Jehad Abubaker, Rong Bu, Abdul K. Siraj, Zeenath Jehan, Nasser Al‐Sanea and Azhar R. Hussain. Their work appears in journals such as Cancer Research, The Journal of Pathology, The American Journal of Human Genetics, The Journal of Clinical Endocrinology & Metabolism and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.